Abstract
The International Union of Pharmacology (IUPHAR) enthusiastically welcomes the decision by the Nature Publishing Group to launch its new journal, Nature Reviews Drug Discovery. The title of the new journal poses interesting questions for pharmacologists. Why 'Drug Discovery'? Would we have preferred 'Pharmacology'? And do these distinctions even matter, as aren't all pharmacologists involved somehow in drug discovery?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
IUPHAR. What is pharmacology? Pharmacol. Int. 53, 2–5 (1999).
Author information
Authors and Affiliations
Corresponding author
Related links
Rights and permissions
About this article
Cite this article
Fredholm, B., Fleming, W., Vanhoutte, P. et al. The role of pharmacology in drug discovery. Nat Rev Drug Discov 1, 237–238 (2002). https://doi.org/10.1038/nrd749
Issue Date:
DOI: https://doi.org/10.1038/nrd749
This article is cited by
-
A novel hybrid framework for metabolic pathways prediction based on the graph attention network
BMC Bioinformatics (2022)
-
VeloceGenomics: An Accelerated in Vivo Drug Discovery Approach to Rapidly Predict the Biologic, Drug-Like Activity of Compounds, Proteins, or Genes
Pharmaceutical Research (2005)
-
A bridge between academia and the drug discovery pipeline
Nature Reviews Drug Discovery (2002)
